Genentech uses an extensive set of criteria, including scientific rationale and medical need, to determine which projects to move from discovery research into development. Our clinical scientists and medical professionals then perform the essential role of translating basic science into patient benefit. They help Genentech determine which potential new drugs are tested against specific diseases in the clinic and guide chosen drug candidates through the many phases of clinical testing.

See our early-stage (PDF/94K) and late-stage (PDF/94k) development pipeline to view Genentech's more than 100 projects in the following therapeutic focus areas: oncology, immunology, disorders of tissue growth and repair, and neuroscience.

If you are having trouble viewing our pipeline in PDF or flash formats, or would like to view our pipeline by phase, click here.